Tauromustine
Tauromustine is an orally active nitrosourea anticancer agent. Tauromustine has an alkylation effect and can damage the DNA function. Tauromustine has a high therapeutic index, especially in the treatment of Walker 256 rat sarcoma. It is also active against melanoma, breast cancer, pleural mesothelioma and ovarian cancer. Tauromustine is mainly metabolized in the liver, but some of its metabolites also have cytotoxicity[1][2][3].
Product Specifications
CAS Number
85977-49-7
UNSPSC
12352211
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=NN(CCCl)C(NCCS(=O)(N(C)C)=O)=O
Molecular Formula
C7H15ClN4O4S
Molecular Weight
286.74
References & Citations
[1]Gregor A, et al. Phase II study of tauromustine in malignant glioma. Eur J Cancer. 1992;28A (12) :1959-62.|[2]Smyth JF, et al. Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. Ann Oncol. 1995 Nov;6 (9) :948-9.|[3]Bibby MC, et al. Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice. Br J Cancer. 1992 Mar;65 (3) :347-50.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal Complement Component C5aR1 Antibody (347234) [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
FAB36481B 0.1 mL
Mouse Monoclonal Complement Component C5aR1 Antibody (347234) [Biotin]
Sign In for Pricing
View Details 
MBS6146038-01 0.1 mL
ATP5I (ATP Synthase Subunit E, Mitochondrial, ATPase Subunit E, ATP5K) (FITC)
Sign In for Pricing
View Details MBS6146038-02 5x 0.1 mL
ATP5I (ATP Synthase Subunit E, Mitochondrial, ATPase Subunit E, ATP5K) (FITC)
Sign In for Pricing
View Details 